← 返回

Talin1 在睾丸生殖细胞肿瘤中表达下调:基于生物信息学与实验方法的联合研究

英文原题:Talin1 is downregulated in testicular germ cell tumors according to combined bioinformatics and experimental approaches.

查看英文原题

Talin1 is downregulated in testicular germ cell tumors according to combined bioinformatics and experimental approaches.

PubMed 2026/01/28(内容时间) Sci Rep Q1 · IF 4.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

Talin1 是一种参与细胞黏附和迁移的黏着斑蛋白,其异常表达与癌症进展相关。然而,其在睾丸生殖细胞肿瘤(TGCTs)中的作用仍不清楚。

本研究旨在通过整合生物信息学和免疫组织化学方法评估 Talin1 在 TGCTs 中的表达。通过 GEO 和蛋白质组学数据集鉴定差异表达基因。Venn 图、基因本体(GO)和蛋白-蛋白相互作用(PPI)分析揭示 Talin1 是细胞黏附和迁移通路中的关键基因。利用 TCGA 和 GTEx 数据评估预后相关性。

进一步通过免疫组织化学在 191 例 TGCT 组织上检测 Talin1 表达。结果显示,Talin1 表达降低与精原细胞瘤(P = 0.036)、胚胎性癌(P = 0.021)和畸胎瘤(P = 0.044)中较高的 pT 分期相关。在胚胎性癌中,其还与静脉侵犯(P = 0.021)和鞘膜侵犯(P = 0.049)显著相关,在卵黄囊瘤中则与门部受累和TIL(肿瘤浸润淋巴细胞)的存在相关。这些发现表明,细胞质 Talin1 表达降低与 TGCTs 中侵袭性肿瘤行为和疾病进展相关。Talin1 可能具有作为 TGCTs 预后生物标志物的潜力,但仍需进一步的功能研究以阐明其机制作用及治疗意义。

展开英文摘要原文

Talin1 is a focal adhesion protein involved in cell adhesion and migration, with abnormal expression linked to cancer progression.

However, its role in testicular germ cell tumors (TGCTs) remains unclear.

This study aimed to evaluate Talin1 expression in TGCTs using integrated bioinformatics and immunohistochemical approaches. Differentially expressed genes were identified through GEO and proteomics datasets. Venn diagram, Gene Ontology (GO), and protein-protein interaction (PPI) analyses revealed Talin1 as a key gene in cell adhesion and migration pathways. Prognostic relevance was assessed using TCGA and GTEx data.

Talin1 expression was further examined via immunohistochemistry on 191 TGCT tissues. Results showed that reduced Talin1 expression was associated with higher pT-stage in seminomas (P = 0. 036), embryonal carcinoma (P = 0. 021), and teratomas (P = 0. 044). It was also significantly linked to venous invasion (P = 0. 021) and tunica vaginalis invasion (P = 0. 049) in embryonal carcinoma, as well as hilum involvement and the presence of tumor-infiltrating lymphocytes in yolk sac tumors.

These findings suggest that decreased cytoplasmic Talin1 expression correlates with aggressive tumor behavior and disease progression in TGCTs. Talin1 may have potential as a prognostic biomarker in TGCTs, though further functional studies are necessary to elucidate its mechanistic role and therapeutic significance.

论文信息

作者
Razmi M、Yazdanpanah A、Vafaei S、Rahimi M、Ghods R、Saki S、Madjd Z、Saeednejad Zanjani L
第一作者单位
Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.Iran
通讯作者单位
Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran. saeednejadleily@yahoo.com.Iran
期刊
Scientific reports2026 Jan 28
原文标识
PubMed 41606050 · DOI 10.1038/s41598-026-37569-w